Analyst ratings, especially from reputable firms like Cantor Fitzgerald, can significantly influence investor sentiment and stock prices. The reiteration of an Overweight rating suggests that the firm has a favorable view of Axsome Therapeutics' prospects, which can lead to increased investor confidence and a short-term rise in the stock price.